Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations

被引:68
作者
Elisei, Rossella [1 ]
Tacito, Alessia [1 ]
Ramone, Teresa [1 ]
Ciampi, Raffaele [1 ]
Bottici, Valeria [1 ]
Cappagli, Virginia [1 ]
Viola, David [1 ]
Matrone, Antonio [1 ]
Lorusso, Loredana [1 ]
Valerio, Laura [1 ]
Giani, Carlotta [1 ]
Campopiano, Cristina [1 ]
Prete, Alessandro [1 ]
Agate, Laura [1 ]
Molinaro, Eleonora [1 ]
Romei, Cristina [1 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Unit Endocrinol, I-56124 Pisa, Italy
关键词
medullary thyroid carcinoma; genetic screening; RET; VUS; MEDULLARY-THYROID CARCINOMA; ENDOCRINE NEOPLASIA TYPE-2; ASSOCIATION GUIDELINES; PROTOONCOGENE; PHENOTYPE; CANCER; MANAGEMENT; FREQUENT; CARRIERS; DISEASE;
D O I
10.3390/genes10090698
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Pathogenic germline mutations affecting the RET proto-oncogene underlie the development of hereditary medullary thyroid carcinoma (MTC). The aims of this study were to evaluate the prevalence of germline RET mutations in a large series of MTC, collected over the last 25 years, and to reappraise their clinical significance. Methods: We performed RET genetic screening in 2031 Italian subjects: patients who presented with sporadic (n = 1264) or hereditary (n = 117) MTC, plus 650 relatives. Results: A RET germline mutation was found in 115/117 (98.3%) hereditary and in 78/1264 (6.2%) apparently sporadic cases: in total, 42 distinct germline variants were found. The V804M mutation was the most prevalent in our cohort, especially in cases that presented as sporadic, while mutations affecting cysteine residues were the most frequent in the group of clinically hereditary cases. All M918T mutations were "de novo" and exclusively associated with MEN2B. Several variants of unknown significance (VUS) were also found. Conclusions: a) RET genetic screening is informative in both hereditary and sporadic MTC; b) the prevalence of different mutations varies with V804M being the most frequent; c) the association genotype-phenotype is confirmed; d) by RET screening, some VUS can be found but their pathogenic role must be demonstrated before screening the family.
引用
收藏
页数:12
相关论文
共 47 条
[1]   Hirschsprung disease, associated syndromes and genetics: a review [J].
Amiel, J. ;
Sproat-Emison, E. ;
Garcia-Barcelo, M. ;
Lantieri, F. ;
Burzynski, G. ;
Borrego, S. ;
Pelet, A. ;
Arnold, S. ;
Miao, X. ;
Griseri, P. ;
Brooks, A. S. ;
Antinolo, G. ;
de Pontual, L. ;
Clement-Ziza, M. ;
Munnich, A. ;
Kashuk, C. ;
West, K. ;
Wong, K. K-Y ;
Lyonnet, S. ;
Chakravarti, A. ;
Tam, P. K-H ;
Ceccherini, I. ;
Hofstra, R. M. W. ;
Fernandez, R. .
JOURNAL OF MEDICAL GENETICS, 2008, 45 (01) :1-14
[2]   A novel germline point mutation, c.2304 G→T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma [J].
Antiñolo, G ;
Marcos, I ;
Fernández, RM ;
Romero, M ;
Borrego, S .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 110 (01) :85-87
[3]   Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease [J].
Arighi, E ;
Popsueva, A ;
Degl'Innocenti, D ;
Borrello, MG ;
Carniti, C ;
Perälä, NM ;
Pierotti, MA ;
Sariola, H .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (04) :1004-1017
[4]   A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A [J].
Berndt, I ;
Reuter, M ;
Saller, B ;
Frank-Raue, K ;
Groth, P ;
Grussendorf, M ;
Raue, F ;
Ritter, MM ;
Höppner, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) :770-774
[5]   Surgical Curability of Medullary Thyroid Cancer in Multiple Endocrine Neoplasia 2B A Changing Perspective [J].
Brauckhoff, Michael ;
Machens, Andreas ;
Lorenz, Kerstin ;
Bjoro, Trine ;
Varhaug, Jan Erik ;
Dralle, Henning .
ANNALS OF SURGERY, 2014, 259 (04) :800-806
[6]  
CARLSON KM, 1994, AM J HUM GENET, V55, P1076
[7]   In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer [J].
Cosci, B. ;
Vivaldi, A. ;
Romei, C. ;
Gemignani, F. ;
Landi, S. ;
Ciampi, R. ;
Tacito, A. ;
Molinaro, E. ;
Agate, L. ;
Bottici, V. ;
Cappagli, V. ;
Viola, D. ;
Piaggi, P. ;
Vitti, P. ;
Pinchera, A. ;
Elisei, R. .
ENDOCRINE-RELATED CANCER, 2011, 18 (05) :603-612
[8]   Predicting Phenotypic Severity of Uncertain Gene Variants in the RET Proto-Oncogene [J].
Crockett, David K. ;
Piccolo, Stephen R. ;
Ridge, Perry G. ;
Margraf, Rebecca L. ;
Lyon, Elaine ;
Williams, Marc S. ;
Mitchell, Joyce A. .
PLOS ONE, 2011, 6 (03)
[9]   A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma:: a detection strategy [J].
Dang, GT ;
Cote, GJ ;
Schultz, PN ;
Khorana, S ;
Decker, RA ;
Gagel, RF .
MOLECULAR AND CELLULAR PROBES, 1999, 13 (01) :77-79
[10]   RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population [J].
Elisei, R ;
Cosci, B ;
Romei, C ;
Bottici, V ;
Sculli, M ;
Lari, R ;
Barale, R ;
Pacini, F ;
Pinchera, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3579-3584